glp-1 oral drugs The challenge of developing alternatives to Ozempic, Wegovy and Mounjaro Why GLP-1 Weight-Loss Drugs Are

As more individuals seek effective solutions for managing their weight, the demand for these medications has surged

We cant say that GLP-1s are actually causing these symptoms, notes Neil Sehgal, the studys first author and a doctoral student in CIS advised by Guntuku and Ungar

The risks rise even further the longer the gap, with up to 22% higher risk of a major cardiovascular event after two years off therapy

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), along with glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) dual or triple receptor agonists that modulate multiple metabolic pathways, have attracted significant scientific interest due to their multifaceted roles in metabolic regulation

To support drug discovery in this field, Axxam has developed a comprehensive metabolic assay platform

The proteins that activate the receptors are called agonists , while the blockers are called antagonists